✦ LIBER ✦
493 Prognostic factors to predict outcomes in patients with HER2-overexpressing metastatic breast cancer treated with trastuzumab containing chemotherapy as first or second line therapy: prognosis grouping according to the prognostic factors
✍ Scribed by M.J. Park; J.H. Park; Y.H. Park; Y.H. Im; J.S. Ahn
- Book ID
- 119601499
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 64 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.